Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adagio Therapeutics Inc. (ADGI)

6.29   -0.15 (-2.33%) 01-21 17:47
Open: 5.62 Pre. Close: 6.44
High: 6.42 Low: 5.73
Volume: 3,109,153 Market Cap: 700M
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.428 - 6.461 6.461 - 6.49
Low: 5.657 - 5.692 5.692 - 5.722
Close: 6.227 - 6.292 6.292 - 6.347

Technical analysis

as of: 2022-01-21 4:24:33 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 14.54     One year: 19.97
Support: Support1: 4.92    Support2: 4.09
Resistance: Resistance1: 12.45    Resistance2: 17.10
Pivot: 6.21
Moving Average: MA(5): 5.90     MA(20): 6.71
MA(100): 27.18     MA(250):
MACD: MACD(12,26): -3.43     Signal(9): -4.23
Stochastic oscillator: %K(14,3): 38.64     %D(3): 27.62
RSI: RSI(14): 36.65
52-week: High: 78.82  Low: 4.92  Change(%): -69.9
Average Vol(K): 3-Month: 8465  10-Days: 6108

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ADGI has closed below upper band by 47.1%. Bollinger Bands are 89.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to Adagio Therapeutics Inc.'s normal range. The bands have been in this narrow range for {EMPTY} bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 21 Jan 2022
48 Biggest Movers From Yesterday - Benzinga

Thu, 20 Jan 2022
Why Shares of Adagio Therapeutics Soared 25.9% on Thursday - The Motley Fool

Thu, 20 Jan 2022
Healthcare Stocks Moving Up and Down Thursday: APM, ADGI, QSI, ICVX, GMVD, VALN, CRDF, EQRX - InvestorsObserver

Wed, 19 Jan 2022
Should Biotechnology Stock Adagio Therapeutics Inc (ADGI) Be in Your Portfolio Wednesday? - InvestorsObserver

Thu, 13 Jan 2022
Adagio Therapeutics shares were trading higher after the company summarized recent findings reported in three separate publications that show ADG20 has neutralization activity against Omicron. - Benzinga

Thu, 13 Jan 2022
Chip stocks, Delta Air Lines, Adagio Therapeutics, Mattel - Reuters

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 111
Shares Float (M) 50
% Held by Insiders 53.50
% Held by Institutions 65.35
Shares Short (K) 7,220
Shares Short P. Month (K) 3,920

Stock Financials

EPS -14.740
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.690
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -135
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -0.43
PEG Ratio
Price to Book value 1.11
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.